EyePoint, Inc.
EYPT Nasdaq· Laboratory Analytical Instruments
Last close · Oct 23, 2026
$0.40
KIRA · Stoqly’s AI analyst, in plain words
- EyePoint, Inc. had $31.4M of revenue in fiscal 2025, down 27.5% on the year before. Over five years, revenue changed −1.8% a year on average.
- Its operating margin was −776.0%, down 438.9 pts: of every 100 in sales, about −776 is left after running the business.
- EyePoint, Inc. lost $232M in fiscal 2025.
- Free cash flow was −$243M in fiscal 2025, −775.8% of revenue.
Market cap
$0.0M
P/E
—
Revenue
$31.4M
Net income
−$232M
Free cash flow
−$243M
Operating margin
−776.0%
EyePoint, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−27.5%
No. Sales fell 27.5% last year.
Does it make a profit?
−739.4%
No. It lost money last year.
Does profit turn into cash?
−775.8%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What EyePoint, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 5, 2026
- Legal name
- EyePoint, Inc.
- CIK
- 0001314102
EyePoint, Inc. · EYPT
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $36.9M | $41.4M | $46.0M | $43.3M | $31.4M |
| Revenue growth | 7.3% | 12.1% | 11.1% | −6.0% | −27.5% |
| Operating margin | −149.6% | −240.6% | −163.1% | −337.1% | −776.0% |
| Net income | −$58.4M | −$102M | −$70.8M | −$131M | −$232M |
| Net margin | −158.1% | −247.0% | −153.8% | −302.4% | −739.4% |
| Diluted EPS | −$2.03 | −$2.74 | −$1.82 | −$2.32 | −$3.17 |
| Cash | |||||
| Cash from operations | −$50.1M | −$65.0M | $1.9M | −$126M | −$240M |
| Capital expenditure | $0.2M | $2.2M | $3.5M | $4.1M | $3.3M |
| Free cash flow | −$50.3M | −$67.2M | −$1.6M | −$130M | −$243M |
| FCF margin | −136.0% | −162.2% | −3.5% | −301.1% | −775.8% |
| Share count change | 124.0% | 29.8% | −99.9% | 44.7% | 30.2% |
| Debt and strength | |||||
| Cash and short-term investments | $212M | $145M | $331M | $371M | $306M |
| Debt incl. finance leases | $36.7M | $40.5M | $0.0M | — | — |
| Shareholders' equity | $184M | $96.4M | $266M | $337M | $306M |
| Current ratio | 10.0x | 5.0x | 5.5x | 7.8x | 8.9x |
| Interest coverage | −10.1x | −31.2x | −60.2x | −10,418.1x | −7,376.8x |
| Returns and quality | |||||
| Return on capital | −465.3% | — | — | — | — |
| Return on equity | −57.6% | −72.8% | −39.0% | −43.4% | −72.2% |
| Return on tangible equity | −36.1% | −106.1% | −26.6% | −38.9% | −75.8% |
| Piotroski F-score | 4 | 2 | 6 | 2 | 1 |
| Altman Z'' | −0.7 | −9.6 | 0.1 | 0.4 | −3.6 |
Insiders bought, 12 months
$0.1M
2 insiders
Insiders sold, 12 months
$0.9M
2 insiders
Of sales under plans
100%
$0.9M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
EyePoint, Inc. · EYPT
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.40 a share, the company is worth $0.0M.
Source: SEC EDGAR XBRL filings (CIK 0001314102). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.